Group 1: Company Performance - In 2024, the company achieved revenue of 18 billion CNY, a year-on-year increase of 3.57% [3] - Net profit attributable to shareholders was 114 million CNY, a decline of 79.23% year-on-year [3] - Total assets amounted to 16.8 billion CNY, with a net asset scale of 7.6 billion CNY [3] - In Q1 2025, revenue was 4.767 billion CNY, a decrease of 6.53% year-on-year, and net profit was 160 million CNY, down 33.83% [3] Group 2: Store Operations - As of December 31, 2024, the number of stores reached 11,498, up from 10,255 at the beginning of the year [6] - In 2025 Q1, the net number of stores decreased by 47, totaling 11,451 stores [6] - The company plans to enhance the operational quality of existing stores rather than focusing on new openings [6] Group 3: Business Development - Retail business aims to reduce reliance on medical insurance payments, targeting a decrease from 30% to below 25% [7] - The company plans to increase the number of traditional Chinese medicine products from 350 to an additional 100 [7] - The medical and health business includes light diagnosis clinics and health management centers [7] Group 4: Market Environment - The consumption market has changed significantly, affecting product demand due to various factors including online and offline dynamics [8] - The industry is experiencing intense competition, with a rapid increase in the number of pharmacies leading to lower per-store output [9] - Regulatory changes may provide consolidation opportunities for leading chain enterprises like Yixin Tang [10] Group 5: Investment and Projects - In 2024, the company repurchased 10,401,300 shares for a total of approximately 134.71 million CNY [11] - Major capital expenditures in 2025 include investments in digitalization and logistics [11] Group 6: Digitalization - The company has implemented cloud services for various operational aspects, enhancing efficiency [12] - Digital applications include customer service, product management, and supply chain tracking [12] Group 7: Medical Insurance Policies - Medical insurance payments currently account for about one-third of total revenue [13] - The company anticipates opportunities for integration and optimization due to stricter medical insurance approvals [15] Group 8: Dividend Distribution - The proposed profit distribution for 2024 is 3 CNY per 10 shares, with a total cash dividend of approximately 172 million CNY [4][19]

Group 1 - The "Yujian Minnan: Time Fantasy" theme park, developed by Xiangyu Group and Dafeng Industrial, aims to become a new benchmark for cultural and commercial tourism integration, with a global public test set to begin on May 1 [1][2] - The project covers an area of 201,000 square meters and features five main chapters that encapsulate Minnan culture, including "Ancient Mountains and Seas" and "Minnan Fantasy," with the first phase set to debut on May 17 [1][2] - Dafeng Industrial's strategy focuses on creating innovative commercial scenarios that integrate cultural experiences, digital consumption, and smart operations, responding to national initiatives to foster new consumption landscapes [2] Group 2 - The project employs advanced technologies such as sensor algorithms and multimedia interactive systems to enhance visitor experiences, creating a high-precision digital interaction foundation [3] - Utilizing industrial-grade digital twin technology, the project transforms cultural IP into tangible experiences, enabling intelligent interaction between people and environments [3] - The establishment of a smart operation system based on IoT and big data analytics aims to upgrade cultural tourism scenarios towards digitalization and intelligence [3]